Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Adrian Anghel Marlena Fejzo |
| Publication date | February 23, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |